Grifols falls on report Brookfield delays offer on funding issues
Brookfield still hasn't managed to obtain the €9.5 billion of bank financing to repay Grifols’ debt, nor the €3.5 billion it ...
New Atlas24d
World-first treatment to prevent long-term eye damage from mustard gas
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...
Seeking Alpha6d
Grifols spikes as banks reportedly finalize offers for buyout debt deal
Grifols' (NASDAQ:GRFS) ADRs gained on Thursday after Bloomberg News reported that several banks are finalizing offers to back nearly €11B ($11.6B) debt package that Brookfield Asset Management ...
Reuters1mon
Grifols SA
European shares struggle ahead of speeches from ECB policymakers 9:30 AM UTC Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after ...